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Educational aims: 
 To discuss the common causes of acute and chronic wet cough in children. 
 To help the reader appreciate the complex interaction between protracted bacterial 
bronchitis and bronchiectasis. 
 To promote a pragmatic approach to the investigation and treatment of children with wet 
cough. 
  
2 
 
Abstract 
When children have a wet cough, it suggests the presence of secretions in their airways. This often 
has an infectious aetiology which is usually a self-limiting viral infection requiring no investigation or 
treatment. In those with acute wet cough it is, however, important to identify features suggestive of 
community acquired pneumonia or an inhaled foreign body as these causes require specific 
management.  When there is chronic wet cough, the most common diagnoses are protracted 
bacterial bronchitis (PBB) and bronchiectasis. The relationship between these two conditions is 
complex as the development of bronchiectasis manifests as a clinical continuum in which the early 
features of which are indistinguishable from PBB. It is therefore important to identify PBB and 
chronic cough endotypes which are associated with an increased risk of bronchiectasis. This article 
offers a pragmatic approach to the investigation and treatment of children with wet cough. It is 
hoped this will limit unnecessary investigations whist aiding the prompt diagnosis of conditions 
needing treatment to reduce symptom burden and prevent further lung damage.  
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Introduction 
Coughing is a protective reflex which clears secretions or inhaled material from the airways.[1] It is 
therefore normal to cough and the mean number of coughing episodes in healthy children has been 
measured as 11 (range 1-34) per 24 hours.[2] In the developed world, increased frequency of cough 
is the commonest reason for a child to be taken to their primary care physician (PCP) and for referral 
into secondary care.[3,4] Cough duration is a primary differentiating factor but frustratingly the 
definitions of acute and chronic cough vary between guidelines. The UK Paediatric Cough guideline 
defines a cough as acute if its duration is <3 weeks, prolonged acute if 3-8 weeks and chronic if >8 
weeks.[5] Other international guidelines define chronic cough as cough with a duration of >4 
weeks.[6,7] The inclusion of ‘prolonged acute’ limits the number of children with post-viral cough 
meeting the criteria for chronic cough who may undergo unnecessary investigations. A proportion of 
children with uncomplicated pertussis may also find their symtpoms resolve during this time. 
Surveys using parental questionnaires have estimate the prevalence of chronic cough (in the 
absence of wheeze) as 5-10%.[8] Chronic cough affects childrens sleep, their ability to play and their 
school performance as well as causing disruption and anxiety for parents and other household 
members.[9] Recurrent cough refers to repeated episodes, not associated with viral illnesses each 
lasting >7–14 days. If the cough-free periods between the episodes are short, it can be difficult to 
distinguish this from chronic cough.[5,10] 
The list of differential diagnoses for chronic cough in children is long[11] and is different to that for 
adults.[12] A helpful way to focus this list is to characterise the cough as wet or dry.[13] Wet, chesty 
and productive are terms used to describe coughs associated with the presence of secretions in the 
airways causing a loose, self-propagating sound. Such coughs often have an infectious aetiology. To 
be grammatically correct, the term ‘productive’ should be reserved for coughs associated with 
sputum expectoration and ‘wet’ for those not associated with this.[14] As most children, however, 
do not expectorate sputum, ‘wet cough’ is commonly used to describe all wet or productive coughs. 
This interpretation of ‘wet cough’ will be used throughout the remainder of this article.  
Acute Wet Cough 
Viral Upper Respiratory Tract Infections 
Two thirds of children aged 0 to 4 years, visit their PCP at least once a year with acute respiratory 
infections, and up to three-quarters of them will have a cough which sounds wet.[15] In the majority 
of cases these episodes are caused by self-limiting, viral, upper respiratory tract infections which do 
not warrant specific treatment.[16,17] The history and examination findings may alert the clinician 
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to consider an alternative diagnosis such as community acquired pneumonia (CAP) or an inhaled 
foreign body.  
Community Acquired Pneumonia 
CAP should be considered if the wet cough is associated with pyrexia (>38.5oC), increased work of 
breathing, tachypnoea or focal chest signs. CAP is a clinical diagnosis and imaging or other additional 
investigations are not routinely required.[18] Viruses are responsible for around half of the cases of 
CAP in chidren and are more common in infants and young children. The most frequently identified 
viruses are RSV, parainfluenza, influenza, human metapneumovirus and human bocavirus.[19,20] 
Bacterial pathogens are responsible for the remaining cases of CAP although some may be a mixed 
viral / bacterial infection.[21] Streptococcus pneumoniae is the commonest bacterial cause of CAP 
being present in up to one third of children >2 years.[22] Other common pathogens are Mycoplasma 
pneumoniae and Chlamydia pneumoniae.[23] When a diagnosis of CAP is made the child should 
receive a course of antibiotics as bacterial and viral pneumonia cannot reliably be distinguished from 
each other.[24] Oral amoxicillin is the first line antibiotic.[18] Intravenous antibiotics are only 
necessary in uncomplicated CAP if the child is unable to take or absorb oral antibiotics (eg vomiting). 
A macrolide should be considered if there is no response to amoxicillin or mycoplasma or Chlamydia 
pneumoniae are suspected.[18] CAP can be complicated by pleural effusion / empyema. This should 
be suspected when there is evidence of effusion on examination (decreased air entry and stony 
dullness to percussion) or persistence of high fever despite adequate antibiotic treatment. 
Ultrasound is more sensitive than CXR at detecting pleural effusions, and avoids the radiation 
associated with computerised tomography (CT) scans.[25] A clinically significant effusion / empyema 
should be drained using chest drain or VATS.[26] 
Inhaled Foreign Body 
Inhalation of a foreign body (FB) is most common in children aged 0-3 years as they tend to explore 
the world around them via their mouths.[27] Food stuffs are implicated in around 80% cases with 
peanuts the number one culprit.[28] At the time of aspiration, common symptoms include coughing, 
choking, and wheezing but these may be self-limiting. If the problem is not diagnosed at the time of 
inhalation it may cause an ensuing infection and the child may ultimately present with wet cough. 
The presence of unilateral chests signs or the history of sudden onset of choking or coughing should 
raise suspicion of inhaled FB. If suspected, a rigid bronchoscopy should be undertaken to find and 
remove the FB.  
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Chronic Wet Cough 
Protracted Bacterial Bronchitis 
Diagnosis 
Protracted bacterial bronchitis (PBB) is the leading cause of chronic wet cough in young children 
living in developed countries. It these areas it is responsible for up to 40% of those referred to 
secondary care with a persistent cough.[29,30] The original definition (now called PBB-micro) was (i) 
history of chronic wet cough, (ii) positive culture of a respiratory pathogen from a bronchoalveolar 
lavage obtained during flexible bronchoscopy (FB-BAL), (iii) response to two weeks oral amoxicillin-
clavulanate acid.[30] When the lower airway is sampled in children with PBB, the most commonly 
identified organisms are Haemophilus influenzae (HiB), Streptococcus pneumoniae, Moraxella 
catarrhalis and Staphylococcus aureus.[31] An alternative definition was developed (PBB-clinical) as 
flexible FB-BAL is unnecessary in children with uncomplicated PBB.[32] Both diagnostic criteria are 
broad, meaning some view PBB as an umbrella term covering a number of different endotypes.[33] 
‘PBB-extended’ and ‘recurrent PBB’ are additional endotypes used to further define PBB.[32] See 
Table 1. These endotypes are clinically relevant  as those with PBB-extended are more likely to have 
tracheo-bronchomalacia[34] and those with recurrent PBB are more likely to have subsequent 
diagnosis of bronchiectasis.[35] 
Table 1: Diagnostic criteria for PBB 
 Diagnostic Criteria 
PBB-micro I. Chronic wet cough (>4 weeks) 
II. Lower airway infection (>104 colony forming units per ml on BAL) 
III. Cough resolution following 2 weeks antibiotics 
PBB-clinical I. Chronic wet cough (>4 weeks) 
II. Absence of symptoms or signs of other causes of wet cough  
III. Cough resolution following 2 weeks antibiotics 
PBB-extended PBB-micro or PBB-clinical but cough only resolves after 4 weeks antibiotics 
Recurrent PBB Recurrent episodes (>3 per year) of PBB 
 
Treatment 
As ‘cough resolution following antibiotic treatment is part of the PBB diagnostic criteria, diagnosis 
cannot be made until the treatment has been completed and the response assessed. Amoxicillin-
clavulanate is the most commonly used first line antibiotic but there is a lack of evidence to guide 
the duration of this course.[36,37] The 2008 UK National Paediatric Cough Guideline suggested 4-6 
weeks.[38] This recommendation was based on expert opinion as there were no prospective studies 
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available at that time. In 2012, a randomised controlled trial (RCT) showed that two weeks of oral 
amoxicillin-clavulanate was associated with higher rates of cough resolution compared to 
placebo.[34] The rate of cough resolution in the treatment group, however, was only 48% which led 
many clinicians to continue using a longer antibiotic course. A survey of UK clinical practice showed 
42% of clinicians prescribed two weeks, 32% four weeks and 26% six weeks of antibiotics. 
International guidelines recommend starting with a two week treatment course and extending it to 
four weeks if cough resolution is not achieved.[14,39]  
Relapse of PBB 
Retrospective reviews report the incidence of chronic cough relapse in PBB as high as 76%.[37] It is 
not known if relapses of PBB reflect incomplete treatment of the original infection or acquisition of a 
new infection. Recurrent PBB (>3 episodes / year) is associated with a future diagnosis of 
bronchiectasis.[35,40] Children with frequent relapses should therefore be considered for 
investigations to exclude bronchiectasis. In this group, the role of antibiotic prophylaxis in preventing 
further relapses and the possible development of bronchiectasis needs further study. The 
relationship between PBB and bronchiectasis is discussed in more detail below.  
Bronchiectasis 
Presentation 
The predominant symptom of bronchiectasis is persistent wet cough which may become 
intermittent if treated with antibiotics. Other features that should alert the clinician to this diagnosis 
include: recurrent lower respiratory tract infections, haemoptysis, chest pain, failure to thrive, 
persistent crackles or wheeze on auscultation, shortness of breath, finger clubbing, unusual 
organisms (i.e. Pseudomonas aeruginosa) isolated from lower airway microbiology samples, 
persistent CXR changes or abnormal spirometry. This array of signs and symptoms highlights the 
potential high burden of bronchiectasis for the child and their family.  
Diagnosis 
Bronchiectasis is conventionally defined as irreversible dilation of the bronchial tree diagnosed using 
CT scan. Other features of bronchiectasis seen on CT scan are listed in Table 2.[41] There is evidence, 
however, that mild bronchiectasis can be reversible if it is appropriately treated or the causative 
factor removed.[42] Clinically this can halt the expected decline in lung function.[43,44] For 
irreversible dilation of the bronchial tree to be confirmed, the child would need to have at least two 
chest CT scans which would be associated with significant radiation exposure.[45] It has therefore 
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been suggested that bronchiectasis should not solely be a radiological diagnosis but instead defined 
as a clinical syndrome which is confirmed radiologically. The suggested syndrome is persistent or 
recurrent (>3) episodes of chronic (>4 weeks) wet cough, sometimes with coarse crackles and finger 
clubbing.[41] Increased broncho-arterial ratio (BAR) measured from chest CT images (obtained with 
a standardised inspiratory volume) should be used as the radiological confirmation. BAR is the inner 
diameter of airway as a ratio to outer diameter of accompanying vessel (within 5mm in a non-
tangential plane). In children an abnormal BAR is defined as >0.80.[41] This is lower than the ratio 
used in adults reflecting different normal values.[46]  
Table 2 – Features of bronchiectasis seen on chest CT. 
 Radiological Feature 
1 Increased broncho-arterial ratio (BAR)# - signet ring sign 
2 Bronchial wall thickening 
3 Lack of bronchial wall tapering - tramlines 
4 Presence of bronchial structures in the lung periphery 
5 Mucus plugging 
6 Air trapping  - mosaic perfusion 
#Defined as the inner diameter of airway as a ratio to outer diameter of accompanying vessel (within 5mm in a non-
tangential plane). 
Causes 
A list of the common causes of bronchiectasis is shown in Table 3. In all these conditions the 
underlying pathophysiology is a cycle of lower airway infection and / or inflammation causing lung 
damage.[47] In the early stages the infection and inflammation is likely to result in chronic wet 
cough before lung damage is severe enough to cause airway dilatation. This phase may be 
indistinguishable from PBB. The longitudinal development of bronchiectasis can therefore manifest 
clinically as an overlapping continuum of PBB, chronic suppurative lung disease (CSLD) and 
eventually bronchiectasis.[40] In addition to the chronic wet cough, children in the first phase are 
likely to have audible and palpable secretions, impaired regional muco-ciliary clearance, 
endobronchial bacterial infection and neutrophilic airway inflammation.[32] As the child moves 
towards CSLD digital clubbing may develop as well as chest wall deformity and auscultatory chest 
signs.[48] The radiological confirmation of airway dilation (likely to start as reversible and then 
becoming fixed) confirms the final phase.  
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Table 3 - Conditions associated with the development of bronchiectasis in children  
 Clinical Features 
(Specific Cough Markers) 
Diagnostic Test 
Mucociliary abnormalities   
Cystic fibrosis (CF) Failure to thrive, steatorrhoea Sweat test, genetics 
Primary ciliary dyskinesia (PCD) Dextrocardia, sinus & ear disease Nasal nitric oxide, ciliary studies 
Infection   
Recurrent PBB >3 episodes PBB/ year None 
Post-LRTI Previous LRTI None 
Post-tuberculosis Previous tuberculosis None 
Post-infective bronchiolitis obliterans LRTIs, crackles, dyspnoea CT scan with expiratory images 
Immunodeficiency   
Primary / secondary / syndrome associated  Recurrent, severe or atypical 
infections 
Immune, genetic or serology blood 
tests 
Lung damage   
Aspiration Neurodevelopmental delay, 
recurrent LRTIs, choking episodes 
Video fluoroscopy 
GORD Vomiting, dyspepsia, water brash pH study / impedance manometry 
Airway abnormalities   
Tracheomalacia / bronchomalacia Brassy cough Bronchoscopy 
Inhaled foreign body Acute choking episode Bronchoscopy 
Pre-existing lung disease   
Allergic bronchopulmonary aspergillosis Dypnoea, wheeze Total IgE, specific IgE, precipitins 
Interstitial / connective tissue lung disease Autoimmune disease, medications Disease specific serology 
Non-post-infectious bronchiolitis obliterans Post transplantation, medication CT scan with expiratory images 
Prematurity Premature birth None 
 
Treatment 
The primary aim of bronchiectasis treatment is to address the underlying cause to stop the 
progression of the disease thus preventing further lung function decline.[43,44] The treatment of 
radiologically confirmed bronchiectasis in children is covered in detail in other review articles.[41,49] 
I have therefore only included the following brief overview. Any underlying cause should be 
addressed. Lower airway infection with pathogenic organisms needs to be identified and treated 
aggressively. This can be accomplished using oral, nebulised or intravenous antibiotics depending on 
the severity of the symptoms. Isolation of virulent organisms such as Pseudomonas aeruginosa 
should prompt attempts at eradication. Prophylactic oral antibiotics with agents such as 
azithromycin can reduce exacerbations but may be associated with antibiotic resistance.[50] As in 
CF, there may be a role for nebulised antibiotics to supress chronic infection with Pseudomonas 
aeruginosa. Airway clearance is viewed by most clinicians as a vital part of clinical care but there is a 
lack of supporting evidence. Dornase alfa is commonly used in CF but has been shown to be harmful 
in non-CF bronchiectasis.[51] Nebulised hypertonic saline is therefore the most widely used 
mucolytic. 
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Other Causes of Chronic Wet Cough 
All the conditions associated with bronchiectasis may present in the early stages with chronic wet 
cough without evidence of CSLD or bronchiectasis. In these children, the aim for the Respiratory 
Paediatrician is to prevent the development of bronchiectasis, or if this is already present, to prevent 
it from worsening. Some causes of chronic wet cough are not associated with bronchiectasis. These 
include the small subset of children with asthma who present with a wet rather than the usual dry 
cough. These children must be carefully evaluated to confirm the diagnosis of asthma and exclude a 
second lung pathology.     
A Pragmatic Approach to the Child with Wet Cough 
Acute Wet Cough 
Most children with acute wet cough require no investigations or treatment as it is caused by a self-
limiting viral infection. A good history and examination should identify children meeting the criteria 
for CAP and those whose symptoms are secondary to an inhaled foreign body.  
Chronic Cough 
A possible approach to the investigation and treatment of children with chronic wet cough is shown 
in Figure 1. The figure demonstrates the paucity of evidence on which most of these decisions are 
made and highlights the need for good quality studies. The first step is a detailed history and 
examination to identify of specific cough markers suggesting an underlying cause. Examples are 
shown in Table 3. If specific cough markers are present, the investigation(s) can be focused and if the 
diagnosis confirmed, appropriate treatment started.  
In children with chronic wet cough but no specific cough markers, assessing the response to 
antibiotics is the next step. In our department, a two week trial of oral amoxicillin-clavulanate is first-
line, extended to four weeks if the cough persists. Cough resolution after two weeks suggests a 
diagnosis of PBB and after four weeks PBB-extended. Children with PBB need to be followed-up to 
assess for relapse. Further episodes of chronic cough can be treated with courses of amoxicillin-
clavulanate. Children with chronic wet cough unresponsive to four weeks antibiotics[52] and those 
with recurrent PBB[35] have increased risk of bronchiectasis so should be investigations 
appropriately. As recurrent PBB has increased risk of bronchiectasis and by definition respond to oral 
antibiotics, there is logic in trying to prevent further episodes and reduce the risk of bronchiectasis 
by prescribing a prophylactic antibiotics. The potential advantages of this need to be balanced 
against the risk of antibiotic resistance which is greatest in those who are non-adherent.[53]  
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Investigations  
The presence of cough specific features shown in Table 3 will guide the clinician regarding the 
investigations needed to confirm the suspected diagnosis. The plan of investigations will need to be 
re-evaluated if the suspected diagnosis is excluded.  See Table 4 for a summary of investigations. 
Microbiology 
Although the invasive nature of FB-BAL means it is unwarranted in children with uncomplicated PBB, 
knowledge of the causative organism is helpful to ensure appropriate antibiotic stewardship.[31] 
Obtaining non-invasive lower airway samples using cough swabs, spontaneously expectorated 
sputum or induced sputum should therefore be considered in any child with a wet cough prior to 
starting antibiotics. FB-BAL should be considered in children with recurrent PBB, radiologically 
confirmed bronchiectasis or chronic wet cough unresponsive to four weeks of antibiotics as it may 
aid diagnosis and guide future treatment. As well as standard culture and sensitivities, TB 
polymerase chain reaction (PCR) / cultures should be considered depending on the risk.[54] A per-
nasal swab for pertussis culture / PCR should be considered in all children with a wet cough lasting 
long than two weeks and in any child whose cough is associated with a whoop.[55]  
Radiology 
In children with acute wet cough, a CXR is not routinely required for the diagnosis of CAP and should 
only be performed if there is doubt about the diagnosis or concerns about complications such as 
pleural effusion.[18] In children with chronic wet cough, a CXR can be useful to exclude significant 
pathology but a normal CXR does not exclude bronchiectasis. High resolution chest CT is the gold 
standard radiological investigation for bronchiectasis. Due to the associated radiation dose,[45] this 
should only be performed if clinically indicated and timed to maximise diagnostic benefit as well as 
limit the need for a repeat scan. If the underlying cause is untreated, the continuum of 
bronchiectasis development means a previously normal chest CT does not exclude future 
bronchiectasis. Chest CT should be considered in children with signs or symptoms of CSLD or those 
at increased risk of developing bronchiectasis, in particular recurrent PBB or chronic wet cough 
unresponsive to four weeks antibiotics. If obliterative bronchiolitis is suspected then expiratory 
images should be obtained to look for air trapping. 
Spirometry 
Spirometry should be performed in all children with chronic wet cough dependent on age and ability 
to co-operate. Children with PBB or mild bronchiectasis are likely to have normal lung function. 
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Bronchodilator reversible airway obstruction suggests asthma. Non reversible airway obstruction or 
a mixed obstructive / restrictive pattern is seen in moderate to severe bronchiectasis.[41]   
Excluding CF  
The implementation of the UK national CF newborn screening program has reduced the number of 
children with CF presenting with chronic wet cough.[56] However, this can still occur due to a missed 
or false negative screen. A sweat test should therefore be undertaken in children with confirmed 
bronchiectasis of unknown aetiology or those with CF specific cough markers. These include failure 
to thrive, steatorrhoea, recurrent LRTIs, isolation of suspicious organisms from lower airway cultures 
(Pseudomonas aeruginosa, Burkholderia cepacia complex), recurrent rectal prolapse, hyponatraemic 
dehydration or pseudo-barters syndrome. 
Excluding PCD 
Children should be considered for PCD testing if they have a persistent wet cough or PCD cough 
specific markers. These include: situs anomalies, congenital cardiac defects, persistent rhinitis, 
chronic middle ear disease (with or without hearing loss), neonatal upper / lower respiratory 
symptoms or neonatal intensive care admittance in a term baby. The diagnostic work-up for PCD 
should include nasal nitric oxide measurement, high speed video analysis (including ciliary beat 
frequency and beat pattern analysis) and ciliary ultrastructure analysis by transmission electron 
microscopy.[57] 
Immunology investigations 
A first line immunodeficiency screen should include a full blood count, IgA, IgE, IgG, IgM together 
with functional antibodies to HiB, pneumococcus and Tetanus.[58] It should be performed in children 
with the relevant cough specific markers, recurrent PBB or wet cough not responding to four weeks 
antibiotics. More in-depth immunological investigations should be considered if immunodeficiency is 
suspected despite first line investigations being normal. Guidance from a Paediatric Immunologist is 
likely to be helpful. 
Gastroenterology Investigations 
Gastro-oesophageal reflux disease is best diagnosed by a pH or impedance study. Aspiration into the 
airway is confirmed using video fluoroscopy.  These investigations are only needed if there is clinical 
suspicion from the history or examination.  
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Table 4 – Investigations for Children with Chronic Wet Cough 
First Line Investigations 
(Consider in all) 
Second Line Investigations 
(Consider in selected children) 
CXR Chest CT 
Non-invasive lower airway microbiology sample Flexible bronchoscopy with BAL 
Spirometry Immunology bloods 
 Sweat test 
 Ciliary studies 
 pH / impedance study 
 Video fluroscopy 
CXR: chest radiograph 
Summary 
The vast majority of children with acute wet cough need no investigation or treatment as the cause 
is a self-limiting viral infection. The challenge for the clinician is to identify those with CAP or an 
inhaled foreign body as they require specific treatment. A small percentage of children with a viral 
illness may develop post-viral cough, continuing to be symptomatic for up to eight weeks. The 
differential diagnosis for children with wet cough of this duration includes pertussis.  
In children from developed countries, PBB is the commonest cause of chronic wet cough. The 
disease course in PBB can by uncomplicated with two weeks of antibiotics resulting in cough 
resolution and no relapse but sadly this is the minority. It is important to identify the endotypes 
associated with relapse or future complications as they may require further investigation and / or 
treatment to prevent further lung damage. These include PBB-extended, recurrent PBB and those 
with a wet cough unresponsive to four weeks of antibiotics.  
Bronchiectasis is caused by a vicious cycle of infection, inflammation and lung damage. This 
manifests clinically as a continuum of PBB, CSLD and eventually bronchiectasis.  In the early stages 
when chronic wet cough is the main / only symptom, the aim of treatment should be stopping the 
development of bronchiectasis. If this is already established, the aim of treatment is to limit 
symptom burden and prevent progression. Preventing the development of lung disease in childhood 
is the key in reducing the burden of respiratory disease in adult life. 
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Directions for future research 
 Investigation of the optimal duration of initial antibiotic treatment in children with 
presumed PBB. 
 Detailed assessment of PBB endotypes and their association with a future diagnosis of 
bronchiectasis. 
 Further investigation into the cause of chronic cough relapse in PBB (new infection versus 
incomplete treatment).  
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Figure One – A possible approach to the investigation and management of children with chronic 
wet cough. Clinical assessments shown in dashed boxes (1assessment made at completion of 
antibiotic course, 2assessment made during follow-up). Management decisions shown in solid boxes 
shaded according to available supporting evidence. 
 
 
